A naturalistic comparison of the efficacy and safety of intramuscular olanzapine and intramuscular levomepromazine in agitated elderly patients with schizophrenia
Hidenobu Suzuki,1 Keishi Gen2 1Department of Psychiatry, Suzuki Clinic, Tokyo, Japan; 2Department of Psychiatry, Seimo Hospital, Gunma, Japan Background: There have not been any reports in Japan clarifying the efficacy and safety of intramuscular (IM) olanzapine and IM levomepromazine in agitated el...
Main Authors: | Suzuki H, Gen K |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-08-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/a-naturalistic-comparison-of-the-efficacy-and-safety-of-intramuscular--a14196 |
Similar Items
-
Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia
by: Katagiri H, et al.
Published: (2018-04-01) -
Safety and effectiveness of rapid-acting intramuscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study
by: Katagiri H, et al.
Published: (2018-01-01) -
Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial
by: Charles Lung-Cheng Huang, et al.
Published: (2015-05-01) -
A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation
by: Katagiri Hideaki, et al.
Published: (2013-01-01) -
Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: A multi-centre, double-blind, randomised clinical trial
by: Esther W. Chan, et al.
Published: (2021-02-01)